Trial intelligence / Profile preview

PRP + HA vs PRP or HA Alone in Athletes With Knee Osteoarthritis

NCT07901153Not yet recruiting

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Apr 2027
Primary completion
Dec 2029
Countries
1
01

Overview

Randomised, double-blind trial of platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA) (3 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Total Score at 12 months. Planned start Apr 2027; status: not yet recruiting.

02

Drugs

platelet-rich plasmahyaluronic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07901153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07901153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call